Rasmus Sørrig

Once-Weekly Semaglutide in Adolescents with Obesity

Daniel Weghuber, Timothy Barrett, Margarita Barrientos‐Pérez et al. · New England Journal of Medicine · 2022 · 638 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk

Mansoor Husain, Stephen C. Bain, Ole Kleist Jeppesen et al. · Diabetes Obesity and Metabolism · 2020 · 209 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials

Hiddo J.L. Heerspink, Ellen M. Apperloo, Melanie J. Davies et al. · Diabetes Care · 2023 · 90 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Smoldering multiple myeloma risk factors for progression: a Danish population‐based cohort study

Rasmus Sørrig, Tobias Wirenfeldt Klausen, Morten Salomo et al. · European Journal Of Haematology · 2015 · 70 citations · Full text

Medicine, Oncology, Clinical Epidemiology +10

Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population

Rasmus Sørrig, Tobias Wirenfeldt Klausen, Morten Salomo et al. · PLoS ONE · 2017 · 51 citations · Full text

Medicine, Hematology, Internal Medicine +15